These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9364188)

  • 21. Antibacterials: spontaneous report analysis for a six years period in Bulgaria.
    Getov I; Dimitrova Z
    Boll Chim Farm; 1999 Apr; 138(4):186-90. PubMed ID: 10422330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme.
    Hill GR; Harrison-Woolrych M
    N Z Med J; 2008 Oct; 121(1283):68-75. PubMed ID: 18841187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital.
    Murphy BM; Frigo LC
    Hosp Pharm; 1993 Dec; 28(12):1199-204, 1240. PubMed ID: 10130617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacovigilance: characteristics of the most widely used drugs in Bulgaria.
    Getov I; Dimitrova Z
    Cent Eur J Public Health; 1999 Aug; 7(3):133-6. PubMed ID: 10499144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatal allergic reactions to antibiotics.
    Cameron C; Maling T
    N Z Med J; 2008 Nov; 121(1286):132-3. PubMed ID: 19098958
    [No Abstract]   [Full Text] [Related]  

  • 26. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center.
    Mey C; Hentschel H; Hippius M; Balogh A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):102-7. PubMed ID: 11911597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug reactions in hospital patients.
    Buechner JS
    Med Health R I; 1998 Feb; 81(2):60-1. PubMed ID: 9505068
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.
    van Puijenbroek EP; Bate A; Leufkens HG; Lindquist M; Orre R; Egberts AC
    Pharmacoepidemiol Drug Saf; 2002; 11(1):3-10. PubMed ID: 11998548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse drug reactions among inpatients in a north Indian referral hospital.
    Uppal R; Jhaj R; Malhotra S
    Natl Med J India; 2000; 13(1):16-8. PubMed ID: 10743370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse drug reactions in a department of pediatric surgery.
    Farrokhi S; Nahvi H; Pourpak Z; Moin M; Majdinasab P; Gholami K; Kazemnejad A
    J Trop Pediatr; 2006 Feb; 52(1):72-3. PubMed ID: 15980025
    [No Abstract]   [Full Text] [Related]  

  • 31. An analysis of the reactivity of vaccines administered in Texas from 1991 through 1999.
    Geier DA; Geier MR
    Tex Med; 2002 Jul; 98(7):50-4. PubMed ID: 12134752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001.
    Kimland E; Rane A; Ufer M; Panagiotidis G
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):493-9. PubMed ID: 15918163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short communication: pattern of adverse drug reaction related queries received by the drug information centre of a tertiary care teaching hospital.
    Jimmy B; Jose J; Rao PG
    Pak J Pharm Sci; 2007 Oct; 20(4):333-9. PubMed ID: 17604259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medication errors: an analysis comparing PHICO's closed claims data and PHICO's Event Reporting Trending System (PERTS).
    Benjamin DM; Pendrak RF
    J Clin Pharmacol; 2003 Jul; 43(7):754-9. PubMed ID: 12856390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the knowledge and attitude to adverse drug reactions reporting among healthcare professionals in Wuhan city].
    Li Q; Zhang SM; Chen HT; Fang SP; Yu X; Liu D; Shi LY; Zeng FD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Oct; 25(10):894-7. PubMed ID: 15631751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.
    Niu MT; Ball R; Woo EJ; Burwen DR; Knippen M; Braun MM;
    Vaccine; 2009 Jan; 27(2):290-7. PubMed ID: 18992783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse drug and medical instrument reactions in a pediatric intensive care unit.
    Farrokhi S; Pourpak Z; Fattahi F; Ashrafi MR; Majdinasab P; Gholami K; Moin M
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):761-2. PubMed ID: 19634150
    [No Abstract]   [Full Text] [Related]  

  • 38. Parental reporting of suspected adverse drug reactions in children in Lagos, Nigeria.
    Oshikoya KA; Senbanjo IO; Njokanma OF
    Arch Dis Child; 2009 Jun; 94(6):469-73. PubMed ID: 19147621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensive monitoring of new drugs based on first prescription signals from pharmacists: a pilot study.
    van Grootheest AC; Groote JK; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2003 Sep; 12(6):475-81. PubMed ID: 14513661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective.
    Tremlett HL; Oger J
    Mult Scler; 2008 Jan; 14(1):94-105. PubMed ID: 17881392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.